Clover Health Investments, Corp. (CLOV)
| Market Cap | 1.76B |
| Revenue (ttm) | 1.49B |
| Net Income (ttm) | -25.11M |
| Shares Out | 506.54M |
| EPS (ttm) | -0.05 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,692,924 |
| Open | 3.600 |
| Previous Close | 3.510 |
| Day's Range | 3.460 - 3.660 |
| 52-Week Range | 0.788 - 4.870 |
| Beta | 2.00 |
| Analysts | Strong Buy |
| Price Target | 4.83 (+39.19%) |
| Earnings Date | May 6, 2025 |
About CLOV
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It operates Clover Assistant, a software platform to execute strategy by enabling physicians to detect, identify, and manage chronic diseases earlier than they otherwise could. The company is based in Wilmington, Delaware. [Read more]
Financial Performance
In 2024, Clover Health Investments's revenue was $1.37 billion, an increase of 8.52% compared to the previous year's $1.26 billion. Losses were -$43.01 million, -79.84% less than in 2023.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for CLOV stock is "Strong Buy." The 12-month stock price forecast is $4.83, which is an increase of 39.19% from the latest price.
News
Clover Health: Stars Are Aligning For GAAP Profitability In FY 2026
Clover reported impressive Q1 earnings with robust topline growth and improving profitability metrics thanks to a 30% YoY increase in its member base. Clover could see $95 million in additional revenu...
Top 3 Health Care Stocks That Could Sink Your Portfolio In Q2
As of May 8, 2025, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Clover Health Investments, Corp. (CLOV) Q1 2025 Earnings Call Transcript
Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2025 Earnings Conference Call May 6, 2025 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Officer Pete...
Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance
First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-year First quarter 2025 Total revenues of $462 million, up 33% year-over-year Medicare Advantage medical costs are in line...
Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure
New whitepaper highlights how a relationship with a Primary Care Physician (“PCP”) that uses Counterpart Assistant is associated with better clinical management, and fewer hospitalizations (18% lower)...
Clover Health Announces Changes to Board of Directors
Thomas L. Tran will become Chairman of the Audit Committee and the Nominating and Corporate Governance Committee, and Lee A. Shapiro will not stand for re-election at the 2025 Annual Shareholders' Mee...
Clover Health to Participate in Upcoming Investor Conferences
WILMINGTON, Del., April 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following in...
Clover Health to Report First Quarter 2025 Financial Results on May 6, 2025
WILMINGTON, Del., April 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 202...
Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage
Dr. Shelly Gupta Brings Over a Decade of Medicare Advantage and Healthcare Leadership Experience Dr. Shelly Gupta Brings Over a Decade of Medicare Advantage and Healthcare Leadership Experience
Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth
Clover Health Investments' AI capabilities are a major driver for its topline and bottom-line improvements in FY 2024. Clover Health's MCR in Q4 represented a decline from Q3, unlike past years, and r...
Counterpart Health Partners with Google Cloud to Improve Clinical Data Access for Physicians
New functionality within Counterpart Assistant uses Google Cloud's Vertex AI Search to give clinicians comprehensive insights across multiple sources of patient health data New functionality within Co...
Clover Health Investments, Corp. (CLOV) Q4 2024 Earnings Call Transcript
Clover Health Investments, Corp. (NASDAQ:CLOV) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Office...
Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance
Full year 2024 GAAP Net loss from continuing operations improves by $164 million year-over-year Full year 2024 Adjusted EBITDA of $70 million, representing an increase of $112 million year-over-year C...
Clover Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
WILMINGTON, Del., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report fourth quarter and full year 2024 financial r...
Clover Health: Watch Out For Volatility Following Q4 Earnings Results
I remain bullish on Clover Health long-term but prefer to Hold until Q4 2024 earnings for higher conviction before initiating a long position in this stock. I believe the 40% YTD rise and 60% retail o...
Clover Health Investments Is Building A Competitive Moat
Clover Health Investments, Corp. is a healthcare provider focused on providing Medicare Advantage plans to seniors. The company's proprietary AI technology helps drive higher reimbursement rates and l...
Clover Health: Undervalued Turnaround Play With Promising SaaS Potential
Clover Health's revenue rose 8% in Q3 2024, driven by a 7% growth in Medicare Advantage premiums, despite exiting low-margin ACO REACH program. Cost control measures are paying off, with salaries and ...
Focus On Costs, Regulatory Outlook For Health Insurers In Q4'24 Earnings Season
Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth quarter of 2024, according to S&P Global Market Intelligence analysis of sell-sid...
Clover Health Reports 27% Growth in Medicare Advantage Membership, Surpassing 100,000 Lives After Strong Annual Election Period
WILMINGTON, Del., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced a 27% year-over-year growth of its Med...
Counterpart Health Deploys Counterpart Assistant with Leading Accountable Care Organization
WILLMINGTON, Del., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), an AI-powered physician enablement platform, today announced it has successfully deployed its Counterpart...
Insurtechs Shine On Wall Street In 2024 As Managed Care Struggles
Insurance technology companies were some of the best performing US insurers on Wall Street over the course of 2024, while the managed care sector had a less resilient year. Root Inc., Clover Health In...
Recent Earnings Disappointment Could Be An Ideal Buying Opportunity For Clover Health
Clover Health's recent performance shows mixed results, with revenue growth but a significant share price drop, presenting a potential buying opportunity. Operational efficiency is improving, with bet...
Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference
JERSEY CITY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Remote-First Company -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chie...
Clover Health: Balancing Innovation And Challenges
Clover Health Investments shows financial progress and challenges in 2024, with a focus on innovative Medicare Advantage plans and technology-driven healthcare solutions. The company achieved a 4.0 ra...
Clover Health: Buy The Dip, Reap The Rewards
Clover's 32% dip following its Q3 earnings could be an opportunity to accumulate shares. Clover continues to grow its topline and improve its bottom line performance. Clover's latest star rating upgra...